Literature DB >> 22265397

Understanding metastasis in pancreatic cancer: a call for new clinical approaches.

David A Tuveson1, John P Neoptolemos.   

Abstract

Although metastasis is a major cause of morbidity and mortality in patients with pancreatic cancer, the requisite events are currently unknown. In this issue of Cell, Haeno et al. and Rhim et al. propose that metastasis occurs much earlier than previously anticipated, with clear implications for improving patient care.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID: 22265397     DOI: 10.1016/j.cell.2011.12.021

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  72 in total

1.  FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?

Authors:  Tanios Bekaii-Saab; Richard M Goldberg
Journal:  Oncologist       Date:  2013

2.  External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy.

Authors:  Gaëtan-Romain Joliat; David Petermann; Nicolas Demartines; Markus Schäfer
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

3.  Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Bhavitavya Nijampatnam; Sadanandan E Velu; Ke-He Ruan; Ming Hu; Jianwei Zhou; Ruiwen Zhang
Journal:  Cancer Res       Date:  2018-09-14       Impact factor: 12.701

4.  Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer.

Authors:  Jing Zhao; Jianya Zhou; Zhen Chen; Bo Wang; Xiuming Zhang; Jianying Zhou; Wei Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 5.  New challenges in perioperative management of pancreatic cancer.

Authors:  Francesco Puleo; Raphaël Maréchal; Pieter Demetter; Maria-Antonietta Bali; Annabelle Calomme; Jean Closset; Jean-Baptiste Bachet; Jacques Deviere; Jean-Luc Van Laethem
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

6.  Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.

Authors:  Gina L Razidlo; Christopher Magnine; Arthur C Sletten; Rachel M Hurley; Luciana L Almada; Martin E Fernandez-Zapico; Baoan Ji; Mark A McNiven
Journal:  Cancer Res       Date:  2015-05-14       Impact factor: 12.701

Review 7.  New biomarkers and targets in pancreatic cancer and their application to treatment.

Authors:  Eithne Costello; William Greenhalf; John P Neoptolemos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-26       Impact factor: 46.802

Review 8.  Management of borderline and locally advanced pancreatic cancer: where do we stand?

Authors:  Jin He; Andrew J Page; Matthew Weiss; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

9.  Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Authors:  Agata I Rembielak; Pooja Jain; Andrew S Jackson; Melanie M Green; Gillian R Santorelli; Gillian A Whitfield; Adrian Crellin; Angel Garcia-Alonso; Ganesh Radhakrishna; James Cullen; M Ben Taylor; Ric Swindell; Catharine M West; Juan Valle; Azeem Saleem; Patricia M Price
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.

Authors:  Xiaole Zhu; Chenyuan Shi; Yunpeng Peng; Lingdi Yin; Min Tu; Qiuyang Chen; Chaoqun Hou; Qiang Li; Yi Miao
Journal:  Cell Prolif       Date:  2017-12-20       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.